TRIM2 and ovarian carcinoma: In another study, related gene sequencing experiments confirmed that the expression of miR-145 in ovarian cancer tissues and cell lines was consistently downregulated compared with that in normal ovarian tissues and further confirmed that TRIM2 was the downstream target gene of miR-145.